# Biotronik AG clinical trials: 40 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 40 trials with Biotronik AG as lead sponsor, 2 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Biotronik AG: 40 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/biotronik-ag

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 40
- Recruiting or not yet: 2
- Read on: November 19, 2026

## Trials

The 25 newest of 40, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 29, 2025 | NCT07091682 | Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions | Biotronik AG | Not applicable | Active not recruiting | Coronary Artery Disease, Atherosclerosis of Coronary Artery, Myocardial Ischemia, Ischemic Heart Disease, Acute... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07091682) |
| January 6, 2025 | NCT06758921 | Prospective, Multicenter, Single-Arm Observational Study to Confirm the Safety and Clinical Performance of the Oscar Peripheral... | Biotronik AG | Observational | Recruiting | Peripheral Arterial Disease, Peripheral Arterial Disease(PAD) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06758921) |
| April 26, 2023 | NCT05831319 | Evaluation of Standard of Care Practices, Procedural Outcomes and In-hospital Complications of Peripheral Endovascular Procedures | Biotronik AG | Observational | Completed | Peripheral Arterial Disease | 380 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05831319) |
| September 14, 2022 | NCT05540223 | Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System | Biotronik AG | Not applicable | Active not recruiting | Coronary Artery Disease, Atherosclerosis, Coronary, Myocardial Ischemia, Ischemic Heart Disease, Acute Coronary... | 1,861 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05540223) |
| April 5, 2021 | NCT04830228 | BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions | Biotronik AG | Observational | Active not recruiting | Peripheral Artery Disease | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04830228) |
| December 22, 2020 | NCT04679740 | Resorbable Magnesium Scaffolds Registry | Biotronik AG | Observational | Recruiting | Coronary Artery Disease | 1,106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04679740) |
| September 18, 2020 | NCT04555174 | BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance Registry | Biotronik AG | Observational | Active not recruiting | Coronary Artery Disease, Myocardial Ischemia | 872 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04555174) |
| January 31, 2020 | NCT04250909 | Retrospective Follow-up of BIOLUX P-I/-II | Biotronik AG | Observational | Completed | Overall Mortality | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04250909) |
| November 8, 2019 | NCT04157153 | First in Men Study: BIOMAG-I | Biotronik AG | Not applicable | Active not recruiting | Coronary Artery Disease | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04157153) |
| October 24, 2019 | NCT04137510 | Bioflow-DAPT Study | Biotronik AG | Phase 4 | Completed | Coronary Artery Disease | 1,948 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04137510) |
| July 26, 2018 | NCT03600961 | BIOFLOW-SV Portugal Registry | Biotronik AG | Observational | Terminated | Ischemic Heart Disease | 173 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03600961) |
| July 26, 2018 | NCT03600948 | BIOFLOW-SV All Comers Registry | Biotronik AG | Observational | Terminated | de Novo, Symptomatic Ischemic Heart Disease, Restenoses, Coronary | 261 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03600948) |
| June 6, 2018 | NCT03547986 | BIO REsponse Adapted Combination Therapy Pilot Study | Biotronik AG | Not applicable | Unknown | Peripheral Arterial Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03547986) |
| February 14, 2017 | NCT03052309 | BIOLUX P-III BENELUX All-Comers Registry | Biotronik AG | Observational | Completed | Peripheral Arterial Disease | 106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03052309) |
| February 14, 2017 | NCT03052296 | BIOLUX P-III SPAIN All-Comers Registry | Biotronik AG | Observational | Completed | Peripheral Arterial Disease | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03052296) |
| February 6, 2017 | NCT03044002 | BIOTRONIK 4French for AMBulatory Peripheral Intervention | Biotronik AG | Observational | Completed | Peripheral Artery Disease, Access Site Complication, Outpatient Treatment | 821 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03044002) |
| September 27, 2016 | NCT02916485 | Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold | Biotronik AG | Not applicable | Suspended | Coronary Artery Disease | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02916485) |
| June 29, 2016 | NCT02817802 | BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV | Biotronik AG | Observational | Unknown | Coronary Artery Disease | 2,066 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02817802) |
| March 23, 2016 | NCT02716220 | Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III) | Biotronik AG | Not applicable | Completed | Coronary Artery Disease, Coronary Artery Stenosis | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02716220) |
| October 28, 2014 | NCT02276313 | BIOLUX P-III All-Comers Passeo-18 Lux Registry | Biotronik AG | Observational | Completed | Atherosclerosis, Peripheral Artery Disease | 880 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02276313) |
| September 25, 2014 | NCT02249000 | BIOVALVE - I / II Clincial Investigation | Biotronik AG | Not applicable | Completed | Heart Valve Diseases, Aortic Valve Stenosis | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02249000) |
| October 10, 2013 | NCT01960504 | First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II) | Biotronik AG | Not applicable | Unknown | Coronary Artery Disease, Coronary Artery Stenosis | 123 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01960504) |
| September 11, 2013 | NCT01939249 | Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent | Biotronik AG | Not applicable | Unknown | Coronary Artery Disease | 585 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01939249) |
| June 4, 2013 | NCT01867736 | BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries | Biotronik AG | Not applicable | Completed | Atherosclerosis, Arteriosclerosis, Vascular Disease, Peripheral Artery Disease | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01867736) |
| March 15, 2013 | NCT01811927 | The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent | Biotronik AG | Not applicable | Terminated | Coronary Artery Disease | 43 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01811927) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1/2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 2 |
| Not applicable | 19 |
| Observational | 17 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 22 |
| Unknown | 7 |
| Active not recruiting | 5 |
| Terminated | 3 |
| Recruiting | 2 |
| Suspended | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Coronary Artery Disease | 19 |
| Peripheral Arterial Disease | 11 |
| Myocardial Ischemia | 6 |
| Atherosclerosis | 4 |
| Angina Pectoris | 3 |
| Coronary Stenosis | 2 |
| Acute Coronary Syndrome | 2 |
| Arteriosclerosis | 2 |
| Vascular Diseases | 2 |
| Constriction, Pathologic | 2 |
| Bites and Stings | 2 |
| Coronary Restenosis | 2 |
| Renal Artery Obstruction | 1 |
| Peripheral Vascular Diseases | 1 |
| Intermittent Claudication | 1 |
| Heart Valve Diseases | 1 |
| Aortic Valve Stenosis | 1 |
| ST Elevation Myocardial Infarction | 1 |
| Non-ST Elevated Myocardial Infarction | 1 |
| Ischemia | 1 |
| Diabetes Mellitus | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Landscaping companies in the United States](https://specstream.ai/data/businesses/landscaping-companies/united-states)
- [Mediterranean restaurants in the United States](https://specstream.ai/data/businesses/mediterranean-restaurants/united-states)
- [Osteopathic practices in the United States](https://specstream.ai/data/businesses/osteopathic-practices/united-states)
- [Plumbers in the United States](https://specstream.ai/data/businesses/plumbers/united-states)
- [Real estate law firms in the United States](https://specstream.ai/data/businesses/real-estate-law-firms/united-states)
- [Smoothie and juice bars in the United States](https://specstream.ai/data/businesses/smoothie-and-juice-bars/united-states)
